TECH Fort Worth Impact Awards 2014 Vol. 2014 | Page 20

Acceleration American Rememberance americanremembrance.com Started as a means of connecting those who have fallen military friends and family and to honor and remember the lives that were given, American Remembrance uses web-based technology to enable families to create and share memories with distant relatives, create a permanent scrapbook where loved ones can share thoughts and set up recurrent flower giving, all from the convenience of a web browser. Ampcare swallotherapy.com Ampcare was established in 2007 to help patients regain the ability to swallow. Ampcare has developed therapeutic neuromuscular stimulation technologies for the treatment of dysphagia (swallowing difficulties). They received FDA clearance to market the Effective Swallowing Protocol (ESP™) Therapy System on October 31, 2013, closed their first round of funding in 2013 and are training therapists domestically and internationally. Compumatrice compumatrice.com CompuMatrice is an IT outsourcing company that specializes in customized IT service delivery with easy and flexible terms at a very low cost. In 2013, CompuMatrice introduced the CareLink360 brand, a suite of products targeted at increasing the customer satisfaction and engagement in the healthcare industry. CareLink360 products addresses the new government mandates in healthcare while at the same time providing a platform that can be extended into the travel and entertainment industry. E3 Water e3water.com E3 Water’s mission is to dramatically increase the quality and availability of water by integrating innovative water and wastewater treatment technologies into markets worldwide with their mobile wastewater treatment technology. In late 2013, the E3 Water mobile plant greatly exceeded company goals when test results indicated that treated water at a Fort Worth wastewater treatment facility was deemed potable. In 2014, the company expects to begin manufacturing mobile plants here in Fort Worth. E-Mist Innovations emistinnovations.com E-Mist Innovations Inc. specializes in disinfecting and sanitizing using proprietary, patented electrostatic technology. E-Mist received notification on April 14 that their patent has been approved.  The company completed and funded its first round of Series A Preferred Stock with Cowtown Angelssm; and on May 1st launched its full Touch Point Healthy service model in the DFW area. Encore Vision Inc. encorevisioninc.com Encore Vision is developing Dioptin™, a patented prescription eye drop treatment for presbyopia, the eye condition that afflicts most people by the age of 40, requiring them to wear reading glasses. In December 2013 Encore Vision, Inc. closed an angel investment round of $5.0 million, including $750,000 from members of the Cowtown Angels, a program of TechFW.  The company is using these funds to further the development of its product and complete Phase 2 clinical trials.  iDid, Inc. idid-inc.com iDid’s apps creates the context that backs your contextual intelligence engine. iDid builds context for your use. Your life is not just your search, your comments and your Likes! Your life is what you do everyday, who you meet, where you go - physical and tangible things. As the newest member company of TechFW, iDid is excited for the great opportunities that lie ahead for the company. 20 Flexible Innovations flexinno.com Flexible Innovations Ltd has developed a unique material with a very high coefficient of friction.   The company’s vision is to make the egrips® brand of products as globally ubiquitous as Velcro® and Post-It® product brands; items which have far reaching universal utility. 2014 marks a landmark year for Flexible Innovations with the company graduating from TechFW and moves into its own building in Fort Worth. Lung Therapeutics, Inc lungtx.com Lung Therapeutics, Inc. is a specialty pharmaceutical company developing ‘first in class’ products to meet the needs of patients with serious lung diseases. The company’s drug has shown promise of reducing fluid buildup and removing scarring in the lungs. The company is currently preparing to start preclinical testing of the drug and is in discussion with angel investors.